{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:44:10Z","timestamp":1790171050789,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.toxlet.2020.06.020","type":"journal-article","created":{"date-parts":[[2020,6,21]],"date-time":"2020-06-21T10:24:34Z","timestamp":1592735074000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Long-term profile of serological biomarkers, hepatic inflammation, and fibrosis in a mouse model of non-alcoholic fatty liver disease"],"prefix":"10.1016","volume":"332","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9700-4531","authenticated-orcid":false,"given":"Riki","family":"Toita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Hun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2020.06.020_bib0005","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jhep.2012.04.041","article-title":"S-adenosylmethionine (SAMe) therapy in liver disease: a review of current evidence and clinical utility","volume":"57","author":"Anstee","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.toxlet.2020.06.020_bib0010","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.2337\/dc14-1239","article-title":"Clinical model for NASH and advanced fibrosis in adult patients with diabetes and NAFLD: guidelines for referral in NAFLD","volume":"38","author":"Bazick","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.toxlet.2020.06.020_bib0015","doi-asserted-by":"crossref","first-page":"G615","DOI":"10.1152\/ajpgi.00414.2009","article-title":"Impact of elevation of total bilirubin level and etiology of the liver disease on serum N-glycosylation patterns in mice and humans","volume":"298","author":"Blomme","year":"2010","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.toxlet.2020.06.020_bib0020","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/liv.12465","article-title":"Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever","volume":"34","author":"Carloni","year":"2014","journal-title":"Liver Int."},{"key":"10.1016\/j.toxlet.2020.06.020_bib0025","doi-asserted-by":"crossref","first-page":"e37241","DOI":"10.1371\/journal.pone.0037241","article-title":"A cohort study of serum bilirubin levels and incident non- alcoholic fatty liver disease in middle aged Korean workers","volume":"7","author":"Chang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.toxlet.2020.06.020_bib0030","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10238-013-0262-5","article-title":"The effect of the severity of liver cirrhosis on the level of lipids and lipoproteins","volume":"14","author":"Chrostek","year":"2014","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.toxlet.2020.06.020_bib0035","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1001\/archinte.1997.00440280120012","article-title":"Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis","volume":"157","author":"Cicognani","year":"1997","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.toxlet.2020.06.020_bib0040","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/MOG.0b013e32834e7b4b","article-title":"Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression","volume":"28","author":"Corbin","year":"2012","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.toxlet.2020.06.020_bib0045","first-page":"586","article-title":"Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study","volume":"47","author":"Eguchi","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.toxlet.2020.06.020_bib0050","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1002\/hep.30333","article-title":"Mouse models of nonalcoholic steatohepatitis: toward optimization of their relevance to human nonalcoholic steatohepatitis","volume":"69","author":"Farrell","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.toxlet.2020.06.020_bib0055","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1194\/jlr.M007096","article-title":"Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"51","author":"Feldstein","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.toxlet.2020.06.020_bib0060","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hep.22429","article-title":"Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes","volume":"48","author":"Fracanzani","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.toxlet.2020.06.020_bib0065","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3164\/jcbn.22.51","article-title":"Lactate dehydrogenase isoenzymes in dimethylnitrosamine-induced hepatic fibrosis in rats","volume":"22","author":"George","year":"1997","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.toxlet.2020.06.020_bib0070","first-page":"285","article-title":"The relationship between lipid profile and severity of liver damage in cirrhotic patients","volume":"210","author":"Ghadir","year":"2010","journal-title":"Hepat. Mon."},{"key":"10.1016\/j.toxlet.2020.06.020_bib0075","first-page":"17","article-title":"A review on laboratory liver function tests","volume":"3","author":"Gowda","year":"2009","journal-title":"Pan Afr. Med. J."},{"key":"10.1016\/j.toxlet.2020.06.020_bib0080","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.drudis.2017.06.007","article-title":"Mouse models of nonalcoholic steatohepatitis in preclinical drug development","volume":"22","author":"Hansen","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.toxlet.2020.06.020_bib0085","first-page":"569","article-title":"The clinical value of lactate dehydrogenase in serum: a quantitative review","volume":"35","author":"Huijgen","year":"1997","journal-title":"Eur. J. Clin. Chem. Clin. Biochem."},{"key":"10.1016\/j.toxlet.2020.06.020_bib0090","first-page":"2683","article-title":"Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL\/6 mice","volume":"6","author":"Itagaki","year":"2013","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.toxlet.2020.06.020_bib0095","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1476-511X-5-4","article-title":"Influence of liver cancer on lipid and lipoprotein metabolism","volume":"5","author":"Jiang","year":"2006","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.toxlet.2020.06.020_bib0100","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(99)00219-6","article-title":"Serum aminotransferase concentration as evidence of hepatocellular damage","volume":"355","author":"Kew","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.toxlet.2020.06.020_bib0105","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4103\/2277-9175.178785","article-title":"Comparison of liver enzymes level and sonographic findings value with liver biopsy findings in nonalcoholic fatty liver disease patients","volume":"5","author":"Khodadoostan","year":"2016","journal-title":"Adv. Biomed. Res."},{"key":"10.1016\/j.toxlet.2020.06.020_bib0110","first-page":"452","article-title":"Non-alcoholic fatty liver disease and correlation of serum alanine aminotransferase level with histopathologic findings","volume":"11","author":"Khosravi","year":"2011","journal-title":"Hepat. Mon."},{"key":"10.1016\/j.toxlet.2020.06.020_bib0115","first-page":"626","article-title":"Alkaline phosphatase: can it be considered as an indicator of liver fibrosis in non-alcoholic steatohepatitis with type 2 diabetes? Bratisl","volume":"112","author":"Kocabay","year":"2011","journal-title":"Lek. Listy."},{"key":"10.1016\/j.toxlet.2020.06.020_bib0120","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3892\/etm.2011.197","article-title":"Lactate dehydrogenase production in hepatocytes is increased at an early stage of acute liver failure","volume":"2","author":"Kotoh","year":"2011","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.toxlet.2020.06.020_bib0125","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3350\/cmh.2012.18.4.383","article-title":"Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease","volume":"18","author":"Kwak","year":"2012","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.toxlet.2020.06.020_bib0130","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/path.4829","article-title":"Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances","volume":"241","author":"Lau","year":"2017","journal-title":"J. Pathol."},{"key":"10.1016\/j.toxlet.2020.06.020_bib0135","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3389\/fgene.2018.00662","article-title":"Genetically regulated bilirubin and risk of non-alcoholic fatty liver disease: a mendelian randomization study","volume":"9","author":"Luo","year":"2018","journal-title":"Front. Genet."},{"key":"10.1016\/j.toxlet.2020.06.020_bib0140","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12876-020-1165-z","article-title":"Proportion of NAFLD patients with normal ALT value in overall NAFLD patients: a systematic review and meta-analysis","volume":"20","author":"Ma","year":"2020","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.toxlet.2020.06.020_bib0145","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1665-2681(19)31355-9","article-title":"S-adenosylmethionine metabolism and liver disease","volume":"12","author":"Mato","year":"2013","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.toxlet.2020.06.020_bib0150","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/hep.27395","article-title":"The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease","volume":"61","author":"Maximos","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.toxlet.2020.06.020_bib0155","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1053\/jhep.2003.50229","article-title":"Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values","volume":"37","author":"Mofrad","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.toxlet.2020.06.020_bib0160","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/hep.25739","article-title":"Nonalcoholic steatohepatitis versus steatosis: adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism","volume":"56","author":"Musso","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.toxlet.2020.06.020_bib0165","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/hep.23784","article-title":"Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease","volume":"52","author":"Neuschwander-Tetri","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.toxlet.2020.06.020_bib0170","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/alcalc\/agh074","article-title":"High AST\/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking","volume":"39","author":"Nyblom","year":"2004","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.toxlet.2020.06.020_bib0175","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/MPG.0b013e318291fefe","article-title":"Serum bilirubin level is inversely associated with nonalcoholic steatohepatitis in children","volume":"57","author":"Puri","year":"2013","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.toxlet.2020.06.020_bib0180","first-page":"189","article-title":"Quantitative estimation of lactate dehydrogenase isoenzymes in serum. I. Review of methods and distribution in human tissues","volume":"36","author":"Roman","year":"1969","journal-title":"Enzymologia"},{"key":"10.1016\/j.toxlet.2020.06.020_bib0185","first-page":"268","article-title":"Alterations in total lactate dehydrogenase and its isoenzyme-5 in hepatic disorders","volume":"20","author":"Rotenberg","year":"1990","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.toxlet.2020.06.020_bib0190","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.3748\/wjg.v21.i11.3223","article-title":"Biomarkers in nonalcoholic fatty liver disease-the emperor has no clothes?","volume":"21","author":"Sanal","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.toxlet.2020.06.020_bib0195","doi-asserted-by":"crossref","first-page":"g4596","DOI":"10.1136\/bmj.g4596","article-title":"Non-alcoholic fatty liver disease","volume":"349","author":"Sattar","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.toxlet.2020.06.020_bib0200","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3945\/an.114.007955","article-title":"Choline, its potential role in nonalcoholic fatty liver disease, and the case for human and bacterial genes","volume":"7","author":"Sherriff","year":"2016","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.toxlet.2020.06.020_bib0205","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1572-0241.1999.01006.x","article-title":"The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease","volume":"94","author":"Sorbi","year":"1999","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.toxlet.2020.06.020_bib0210","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/hep.23594","article-title":"Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection","volume":"51","author":"Starley","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.toxlet.2020.06.020_bib0215","doi-asserted-by":"crossref","first-page":"31006","DOI":"10.1038\/srep31006","article-title":"Association between bilirubin and risk of Non-Alcoholic Fatty Liver Disease based on a prospective cohort study","volume":"6","author":"Tian","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.toxlet.2020.06.020_bib0220","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1293\/tox.2017-0038","article-title":"Increased hepatic inflammation in a normal-weight mouse after long-term high-fat diet feeding","volume":"31","author":"Toita","year":"2018","journal-title":"J. Toxicol. Pathol."},{"key":"10.1016\/j.toxlet.2020.06.020_bib0225","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.toxlet.2020.06.020_bib0230","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/liv.12226","article-title":"Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD)","volume":"33","author":"Verma","year":"2013","journal-title":"Liver Int."},{"key":"10.1016\/j.toxlet.2020.06.020_bib0235","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.toxlet.2020.06.020_bib0240","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41575-018-0014-9","article-title":"Noninvasive biomarkers in NAFLD and NASH - current progress and future promise","volume":"15","author":"Wong","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.toxlet.2020.06.020_bib0245","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.mri.2016.03.009","article-title":"Gd-EOB-DTPA-enhanced-MR imaging in the inflammation stage of nonalcoholic steatohepatitis (NASH) in mice","volume":"34","author":"Yamada","year":"2016","journal-title":"Magn. Reason. Imaging"},{"key":"10.1016\/j.toxlet.2020.06.020_bib0250","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ejim.2011.01.011","article-title":"Alterations in lipid, carbohydrate and iron metabolism in patients with non-alcoholic steatohepatitis (NASH) and metabolic syndrome","volume":"22","author":"Zimmermann","year":"2011","journal-title":"Eur. J. Intern. Med."}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427420302939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427420302939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T05:18:56Z","timestamp":1759900736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427420302939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":50,"alternative-id":["S0378427420302939"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2020.06.020","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term profile of serological biomarkers, hepatic inflammation, and fibrosis in a mouse model of non-alcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2020.06.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}